Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

NCT04992988 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Toripalimab
Recurrent Nasopharyngeal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab

Sponsor

Cancer Hospital of Guangxi Medical University